US5889136A
(en)
|
1995-06-09 |
1999-03-30 |
The Regents Of The University Of Colorado |
Orthoester protecting groups in RNA synthesis
|
EP2428568B1
(en)
*
|
2001-09-28 |
2018-04-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
EP1648914A4
(en)
*
|
2003-07-31 |
2009-12-16 |
Regulus Therapeutics Inc |
OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA
|
US20050261217A1
(en)
|
2004-05-18 |
2005-11-24 |
Isis Pharmaceuticals Inc. |
Modulation of pumilio 1 expression
|
US20070259349A1
(en)
|
2006-05-04 |
2007-11-08 |
Itzhak Bentwich |
Bladder cancer-related nucleic acids
|
US7825229B2
(en)
|
2005-03-25 |
2010-11-02 |
Rosetta Genomics Ltd. |
Lung cancer-related nucleic acids
|
US7642348B2
(en)
|
2004-10-04 |
2010-01-05 |
Rosetta Genomics Ltd |
Prostate cancer-related nucleic acids
|
US7592441B2
(en)
|
2004-10-04 |
2009-09-22 |
Rosetta Genomics Ltd |
Liver cancer-related nucleic acids
|
CA2850323A1
(en)
|
2004-11-12 |
2006-12-28 |
Asuragen, Inc. |
Methods and compositions involving mirna and mirna inhibitor molecules
|
WO2006119365A2
(en)
|
2005-05-02 |
2006-11-09 |
Cold Spring Harbor Laboratory |
Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster
|
WO2006128245A1
(en)
|
2005-06-03 |
2006-12-07 |
Southern Adelaide Health Service-Flinders Medical Centre |
Targeting cells with altered microrna expression
|
US20090209621A1
(en)
|
2005-06-03 |
2009-08-20 |
The Johns Hopkins University |
Compositions and methods for decreasing microrna expression for the treatment of neoplasia
|
CN105902559A
(zh)
|
2005-08-01 |
2016-08-31 |
俄亥俄州立大学研究基金会 |
用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
|
CN101296702B
(zh)
*
|
2005-09-12 |
2012-11-28 |
俄亥俄州立大学研究基金会 |
用于诊断或治疗bcl2相关癌症的组合物和方法
|
EP2468890B1
(en)
|
2006-01-05 |
2014-03-19 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers of the breast or lung
|
EP2586455B1
(en)
|
2006-01-05 |
2014-06-25 |
The Ohio State University Research Foundation |
MicroRNA expressions abnormalities in pancreatic endocrine and acinar tumors
|
CN103993082B
(zh)
|
2006-01-05 |
2017-01-11 |
俄亥俄州立大学研究基金会 |
用于肺癌的诊断、预后和治疗的基于微小rna 的方法和组合物
|
EP2522750A1
(en)
|
2006-03-02 |
2012-11-14 |
The Ohio State University |
MicroRNA expression profile associated with pancreatic cancer
|
EP2369013A1
(en)
|
2006-03-20 |
2011-09-28 |
The Ohio State University Research Foundation |
Micro-RNA fingerprints during human megakaryocytopoiesis
|
EA201100811A1
(ru)
|
2006-04-03 |
2012-06-29 |
Сантарис Фарма А/С |
Фармацевтическая композиция
|
US20100004320A1
(en)
|
2006-04-03 |
2010-01-07 |
Santaris Pharma A/S |
Pharmaceutical Composition
|
US20080076674A1
(en)
|
2006-07-06 |
2008-03-27 |
Thomas Litman |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of non coding RNAs associated with cancer
|
EP2455492B1
(en)
|
2006-07-13 |
2013-11-20 |
The Ohio State University Research Foundation |
Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases
|
WO2008014008A2
(en)
|
2006-07-28 |
2008-01-31 |
The Johns Hopkins University |
Compositions and methods for modulating angiogenesis
|
WO2008036741A2
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-200 regulated genes and pathways as targets for therapeutic intervention
|
CA2663812A1
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-143 regulated genes and pathways as targets for therapeutic intervention
|
US8188255B2
(en)
|
2006-10-20 |
2012-05-29 |
Exiqon A/S |
Human microRNAs associated with cancer
|
EP2090665A2
(en)
|
2006-10-20 |
2009-08-19 |
Exiqon A/S |
Novel human microRNAs associated with cancer
|
US20090137504A1
(en)
|
2006-12-21 |
2009-05-28 |
Soren Morgenthaler Echwald |
Microrna target site blocking oligos and uses thereof
|
EP3536788A1
(en)
|
2006-12-21 |
2019-09-11 |
QIAGEN GmbH |
Microrna target site blocking oligos and uses thereof
|
WO2008092099A2
(en)
|
2007-01-26 |
2008-07-31 |
Rosetta Genomics, Ltd. |
Compositions and methods for treating hematopoietic malignancies
|
US20100310583A1
(en)
|
2007-01-31 |
2010-12-09 |
Immune Disease Institute |
Let-7 microrna and mimetics thereof as therapeutics for cancer
|
US9006206B2
(en)
|
2007-02-27 |
2015-04-14 |
Rosetta Genomics Ltd. |
Composition and methods for modulating cell proliferation and cell death
|
AU2008247427A1
(en)
|
2007-05-03 |
2008-11-13 |
Rosetta Inpharmatics Llc |
Compositions comprising miR34 therapeutic agents for treating cancer
|
KR20100049079A
(ko)
*
|
2007-07-18 |
2010-05-11 |
더 리젠트스 오브 더 유니버시티 오브 콜로라도 |
인간의 정상 심장과 기능부진 심장에서 마이크로 rna의 차등 발현
|
JP5401460B2
(ja)
|
2007-09-06 |
2014-01-29 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ヒト卵巣癌中のマイクロrnaシグネチャー
|
AU2008298744B8
(en)
*
|
2007-09-14 |
2015-01-15 |
The Ohio State University Research Foundation |
MiRNA expression in human peripheral blood microvesicles and uses thereof
|
WO2009036332A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Asuragen, Inc. |
Micrornas differentially expressed in cervical cancer and uses thereof
|
US20090136957A1
(en)
|
2007-09-15 |
2009-05-28 |
Irena Ivanovska |
Methods and compositions for regulating cell cycle progression via the miR-106B family
|
US20100285471A1
(en)
|
2007-10-11 |
2010-11-11 |
The Ohio State University Research Foundation |
Methods and Compositions for the Diagnosis and Treatment of Esphageal Adenocarcinomas
|
CN101980712B
(zh)
|
2007-10-29 |
2015-02-18 |
雷古拉斯治疗公司 |
用于肝癌治疗的靶向微小rna
|
US20110009469A1
(en)
|
2007-12-05 |
2011-01-13 |
The Johns Hopkins University |
Compositions and methods of treating neoplasia
|
US20110054009A1
(en)
|
2008-02-28 |
2011-03-03 |
The Ohio State University Research Foundation |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
|
US8252760B2
(en)
|
2008-03-24 |
2012-08-28 |
New York University |
Compositions and methods for diagnosing and treating melanoma
|
US20090253780A1
(en)
|
2008-03-26 |
2009-10-08 |
Fumitaka Takeshita |
COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
|
US20100113284A1
(en)
|
2008-04-04 |
2010-05-06 |
Alexander Aristarkhov |
Small interfering rna (sirna) target site blocking oligos and uses thereof
|
US20090258928A1
(en)
|
2008-04-08 |
2009-10-15 |
Asuragen, Inc. |
Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
|
US20110166200A1
(en)
|
2008-04-24 |
2011-07-07 |
Zhan Zhang |
Methods of using mir210 as a biomarker for hypoxia and as a therapeutic agent for treating cancer
|
EP2296669B1
(en)
|
2008-05-30 |
2012-03-21 |
Yale University |
Targeted oligonucleotide compositions for modifying gene expression
|
US20110071215A1
(en)
|
2008-06-02 |
2011-03-24 |
Harvey Pass |
Compositions and methods for diagnosis, prognosis and treatment of mesothelioma
|
EP2300017A4
(en)
*
|
2008-06-05 |
2012-12-12 |
Univ New York State Res Found |
ARNMI AS THERAPEUTIC TARGETS IN CANCER
|
US9540695B2
(en)
|
2008-06-17 |
2017-01-10 |
Rosetta Genomics Ltd. |
Compositions and methods for prognosis of ovarian cancer
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
US20110118337A1
(en)
|
2008-07-10 |
2011-05-19 |
Merck Sharp & Dohme Corp. |
Method of Using Compositions Comprising MIR-192 and/or MIR-215 for the Treatment of Cancer
|
WO2010023658A2
(en)
|
2008-08-28 |
2010-03-04 |
Rosetta Genomics Ltd. |
Compositions and methods for the treatment of glioblastoma
|
MY188457A
(en)
|
2008-10-03 |
2021-12-10 |
Opko Curna Llc |
Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1
|
WO2010065630A2
(en)
|
2008-12-03 |
2010-06-10 |
The Johns Hopkins University |
Compositions and methods for treating hepatic neoplasia
|
KR101866152B1
(ko)
|
2008-12-04 |
2018-06-08 |
큐알엔에이, 인크. |
종양 억제 유전자에 대한 천연 안티센스 전사체의 억제에 의해 종양 억제 유전자 관련된 질환의 치료
|
RU2551234C2
(ru)
|
2008-12-04 |
2015-05-20 |
КьюРНА,Инк.,US |
Лечение сиртуин 1 (sirt1)-связанных заболеваний путем ингибирования натурального антисмыслового транскрипта
|
MX2011005912A
(es)
|
2008-12-04 |
2011-06-17 |
Opko Curna Llc |
Tratamiento de enfermedades relacionadas con factor de crecimiento endotelial vascular por inhibicion de transcrito antisentido natural para factor de crecimiento endotelial vascular.
|
US20110275534A1
(en)
|
2008-12-05 |
2011-11-10 |
The Ohio State University |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
|
US20100311815A1
(en)
|
2009-02-23 |
2010-12-09 |
The Regents Of The University Of Michigan |
Mir-101 cancer markers
|
JP5755569B2
(ja)
*
|
2009-02-25 |
2015-07-29 |
セファイド |
肺癌を検出する方法
|
WO2010102058A2
(en)
|
2009-03-04 |
2010-09-10 |
Curna, Inc. |
Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1
|
US8735568B2
(en)
|
2009-03-09 |
2014-05-27 |
The J. David Gladstone Institutes |
Methods of modulating smooth muscle cell proliferation and differentiation
|
WO2010108192A1
(en)
*
|
2009-03-20 |
2010-09-23 |
The Research Foundation Of State University Of New York |
Mirnas as therapeutic targets in cancer
|
WO2010115050A2
(en)
*
|
2009-04-01 |
2010-10-07 |
The Regents Of The University Of California |
Embryonic stem cell specific micrornas promote induced pluripotency
|
CN104087662A
(zh)
*
|
2009-04-29 |
2014-10-08 |
阿姆斯特丹大学学术医学中心 |
对抗、预防和/或测定心力衰竭或心力衰竭的风险的工具和方法
|
NO2424987T3
(pt)
|
2009-05-01 |
2018-04-14 |
|
|
KR101722541B1
(ko)
|
2009-05-06 |
2017-04-04 |
큐알엔에이, 인크. |
Ttp에 대한 천연 안티센스 전사체의 억제에 의한 트리스테트라프롤린 관련된 질환의 치료
|
KR100998365B1
(ko)
*
|
2009-06-29 |
2010-12-06 |
압타바이오 주식회사 |
치료 효능이 있는 변형핵산 및 구아노신을 함유하는 올리고뉴클레오티드 변형체
|
WO2011014980A1
(en)
|
2009-08-07 |
2011-02-10 |
Capitalbio Corporation |
Methods and compositions diagnosing cervical cancer and cervical dysplasia, guidding subsequent treatment, determining prognosis, and improving patient survival
|
US8822144B2
(en)
|
2009-08-19 |
2014-09-02 |
Rosetta Genomics Ltd. |
Compositions and methods for prognosis and treatment of prostate cancer
|
WO2011024157A1
(en)
|
2009-08-23 |
2011-03-03 |
Rosetta Genomics Ltd. |
Nucleic acid sequences related to cancer
|
WO2011030334A1
(en)
|
2009-09-09 |
2011-03-17 |
New York University |
Compositions and methods for treatment, diagnosis and prognosis of mesothelioma
|
US8648017B2
(en)
*
|
2009-11-04 |
2014-02-11 |
Diamir, Llc |
Methods of using small RNA from bodily fluids for diagnosis and monitoring of neurodegenerative diseases
|
RU2639550C2
(ru)
|
2009-12-16 |
2017-12-21 |
Курна, Инк. |
Лечение заболеваний, связанных с сайт-1 мембраносвязанной пептидазой транскрипционных факторов (mbtps1), путем ингибирования природного антисмыслового транскрипта к mbtps1
|
WO2011090741A2
(en)
|
2009-12-29 |
2011-07-28 |
Opko Curna, Llc |
TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
|
WO2011082409A2
(en)
|
2010-01-04 |
2011-07-07 |
Curna, Inc. |
Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
|
US8846631B2
(en)
|
2010-01-14 |
2014-09-30 |
Regulus Therapeutics Inc. |
MicroRNA compositions and methods
|
WO2011091390A2
(en)
|
2010-01-25 |
2011-07-28 |
Opko Curna, Llc |
Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
|
US8962586B2
(en)
|
2010-02-22 |
2015-02-24 |
Curna, Inc. |
Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
|
WO2011108930A1
(en)
*
|
2010-03-04 |
2011-09-09 |
Interna Technologies Bv |
A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT
|
WO2011113030A2
(en)
|
2010-03-11 |
2011-09-15 |
H.Lee Moffitt Cancer Center & Research Institute |
Human cancer micro-rna expression profiles predictive of chemo-response
|
WO2011116152A2
(en)
|
2010-03-16 |
2011-09-22 |
Sanford -Burnham Medical Research Institute |
Delivery of agents using interfering nanoparticles
|
JP5978203B2
(ja)
|
2010-04-09 |
2016-08-24 |
カッパーアールエヌエー,インコーポレイテッド |
Fgf21に対する天然アンチセンス転写物の阻害による線維芽細胞増殖因子(fgf21)線維芽細胞増殖因子fgf21)関連疾患の治療
|
WO2011128886A1
(en)
|
2010-04-12 |
2011-10-20 |
Ramot At Tel Aviv University Ltd. |
A micro-rna for cancer diagnosis, prognosis and therapy
|
TWI531370B
(zh)
|
2010-05-14 |
2016-05-01 |
可娜公司 |
藉由抑制par4天然反股轉錄本治療par4相關疾病
|
WO2011146674A2
(en)
|
2010-05-19 |
2011-11-24 |
Opko Curna Llc |
Treatment of bcl2-like 11 (bcl2l11) related diseases by inhibition of natural antisense transcript to bcl2l11
|
EP3299464B1
(en)
|
2010-05-26 |
2019-10-02 |
CuRNA, Inc. |
Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
|
WO2011157294A1
(en)
|
2010-06-16 |
2011-12-22 |
Universita' Degli Studi Di Padova |
Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
|
TW201209163A
(en)
|
2010-07-12 |
2012-03-01 |
Opko Curna Llc |
Treatment of BCL2 binding component 3 (BBC3) related diseases by inhibition of natural antisense transcript to BBC3
|
US9333218B2
(en)
*
|
2010-07-15 |
2016-05-10 |
Emory University |
MicroRNA compositions and methods related thereto
|
US20130123138A1
(en)
|
2010-07-25 |
2013-05-16 |
New York University |
Compositions and methods for prognosis of mesothelioma
|
EP2598657B1
(en)
|
2010-08-01 |
2016-10-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Microrna patterns for the diagnosis, prognosis and treatment of melanoma
|
EP2625274B1
(en)
|
2010-10-06 |
2017-07-19 |
CuRNA, Inc. |
Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
|
KR101343616B1
(ko)
|
2010-10-08 |
2013-12-20 |
연세대학교 산학협력단 |
췌장암 치료용 약제학적 조성물 및 췌장암 치료제 스크리닝 방법
|
DK2638163T3
(en)
|
2010-11-12 |
2017-07-24 |
Massachusetts Gen Hospital |
POLYCOMB-ASSOCIATED NON-CODING RNAs
|
US20140045924A1
(en)
|
2010-12-15 |
2014-02-13 |
Medimmune, Llc |
Melanoma treatments
|
US8969315B2
(en)
*
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
US8883757B2
(en)
|
2011-01-03 |
2014-11-11 |
Rosetta Genomics Ltd. |
Compositions and methods for treatment of ovarian cancer
|
EP2474617A1
(en)
*
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
Mir for treating neo-angiogenesis
|
CA2826043A1
(en)
*
|
2011-02-03 |
2012-08-09 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-124
|
US9132152B2
(en)
|
2011-02-10 |
2015-09-15 |
The Regents Of The University Of California |
Compositions and methods for generating induced pluripotent stem cells
|
US20120264131A1
(en)
|
2011-03-18 |
2012-10-18 |
Baylor Research Institute |
CHANGES IN THE EXPRESSION OF miR-200c/141 CLUSTER OF microRNAs AS BIOMARKERS FOR EPITHELIAL-TO-MESENCHYMAL TRANSITION IN HUMAN COLORECTAL CANCER METASTASIS
|
US8987224B2
(en)
*
|
2011-08-05 |
2015-03-24 |
Baylor College Of Medicine |
MicroRNA-198 as a tumor suppressor in pancreatic cancer
|
WO2013056216A1
(en)
*
|
2011-10-14 |
2013-04-18 |
New York University |
Micrornas and methods of using same
|
EP3106168A3
(en)
|
2011-11-30 |
2017-02-22 |
Cedars-Sinai Medical Center |
Targeting micrornas mir-409-5p, mir-379 and mir-154* to treat prostate cancer bone metastasis and drug resistant lung cancer
|
US9745578B2
(en)
|
2011-11-30 |
2017-08-29 |
Cedars-Sinai Medical Center |
Targeting microRNA miR-409-3P to treat prostate cancer
|
US20140363469A1
(en)
*
|
2012-01-19 |
2014-12-11 |
Alnylam Pharmaceuticals, Inc. |
Viral attenuation and vaccine production
|
TR201815503T4
(tr)
|
2012-03-15 |
2018-11-21 |
Curna Inc |
Beyin kaynaklı nörotrofik faktör (bknf) ile ilişkili hastalıkların doğal antisens transkriptinin bknf'ye inhibisyonu ile muamelesi.
|
US20150211004A1
(en)
*
|
2012-04-20 |
2015-07-30 |
Agency For Science, Technology And Research |
Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
|
AU2013262709A1
(en)
|
2012-05-16 |
2015-01-22 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating MECP2 expression
|
WO2013173601A1
(en)
|
2012-05-16 |
2013-11-21 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating bdnf expression
|
AU2013262706A1
(en)
|
2012-05-16 |
2015-01-22 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating PTEN expression
|
AU2013262658A1
(en)
|
2012-05-16 |
2015-01-22 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating APOA1 and ABCA1 expression
|
KR20150030205A
(ko)
|
2012-05-16 |
2015-03-19 |
라나 테라퓨틱스, 인크. |
Smn 유전자 패밀리 발현을 조절하기 위한 조성물 및 방법
|
EA201492122A1
(ru)
|
2012-05-16 |
2015-10-30 |
Рана Терапьютикс, Инк. |
Композиции и способы для модулирования экспрессии utrn
|
US10174323B2
(en)
|
2012-05-16 |
2019-01-08 |
The General Hospital Corporation |
Compositions and methods for modulating ATP2A2 expression
|
AU2013262663A1
(en)
|
2012-05-16 |
2015-01-22 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
Compositions and methods for modulating gene expression
|
EP2850188A4
(en)
|
2012-05-16 |
2016-01-20 |
Rana Therapeutics Inc |
COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF THE MULTIGENIC FAMILY OF HEMOGLOBIN
|
WO2014011975A2
(en)
|
2012-07-12 |
2014-01-16 |
Baylor College Of Medicine |
Micrornas sensitize cancers to therapy
|
US9096853B2
(en)
*
|
2012-09-24 |
2015-08-04 |
U.S. Department Of Veterans Affairs |
Modified siRNA molecules incorporating 5-fluoro-2′-deoxyuridine residues to enhance cytotoxicity
|
CN114177166A
(zh)
|
2012-10-31 |
2022-03-15 |
洛克菲勒大学 |
结肠癌的治疗和诊断
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
WO2014100252A1
(en)
*
|
2012-12-18 |
2014-06-26 |
University Of Washington Through Its Center For Commercialization |
Methods and compositions to modulate rna processing
|
WO2014186462A1
(en)
*
|
2013-05-15 |
2014-11-20 |
The Research Foundation For The State University Of New York |
Microrna-129 as a biomarker for colorectal cancer
|
US20160122760A1
(en)
|
2013-06-07 |
2016-05-05 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating foxp3 expression
|
WO2014201417A1
(en)
*
|
2013-06-14 |
2014-12-18 |
The University Of Kansas |
Methods and compositions of modulating tumor initiating cells and the use thereof
|
WO2015066034A1
(en)
*
|
2013-10-28 |
2015-05-07 |
Icahn School Of Medicine At Mount Sinai |
Compositions and methods for modulating neuronal excitability and motor behavior
|
WO2015095862A2
(en)
|
2013-12-20 |
2015-06-25 |
The Feinstein Institute For Medical Research |
Microrna biomarkers for ovarian cancer
|
EP3105327A4
(en)
|
2014-02-12 |
2017-10-18 |
Thomas Jefferson University |
Compositions and methods of using microrna inhibitors
|
KR101596166B1
(ko)
|
2014-10-07 |
2016-02-19 |
가톨릭대학교 산학협력단 |
유방암 진단 및 치료를 위한 마이크로 rna의 용도
|
WO2016149455A2
(en)
|
2015-03-17 |
2016-09-22 |
The General Hospital Corporation |
The rna interactome of polycomb repressive complex 1 (prc1)
|
ES2965461T3
(es)
|
2015-08-03 |
2024-04-15 |
Biokine Therapeutics Ltd |
Inhibidor de CXCR4 para el tratamiento del cáncer
|
US10053696B2
(en)
|
2016-01-21 |
2018-08-21 |
University Of South Carolina |
MiRNA-489 in treatment of breast cancer
|
CN110290794A
(zh)
|
2016-11-01 |
2019-09-27 |
纽约州州立大学研究基金会 |
5-卤代尿嘧啶修饰的微rna及其在癌症治疗中的用途
|
US11236337B2
(en)
|
2016-11-01 |
2022-02-01 |
The Research Foundation For The State University Of New York |
5-halouracil-modified microRNAs and their use in the treatment of cancer
|
US10443055B2
(en)
|
2016-12-22 |
2019-10-15 |
Beth Israel Deaconess Medical Center |
Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
|
WO2018129402A1
(en)
|
2017-01-06 |
2018-07-12 |
Oregon Health & Science University |
Compositions and methods used in diagnosing and treating colorectal cancer
|
WO2018136919A2
(en)
|
2017-01-23 |
2018-07-26 |
Trustees Of Boston University |
Methods relating to lung cancer
|
KR101953300B1
(ko)
|
2018-06-22 |
2019-02-28 |
의료법인 성광의료재단 |
탁산계 항암제 내성 암의 진단 및 치료를 위한 조성물, 키트 및 방법
|
US20220298516A1
(en)
|
2018-09-20 |
2022-09-22 |
Modernatx, Inc. |
Compositions and methods for delivery of nucleic acids
|
EP3880310A1
(en)
|
2018-11-13 |
2021-09-22 |
Regulus Therapeutics Inc. |
Microrna compounds and methods for modulating mir-10b activity
|
WO2020154207A1
(en)
|
2019-01-22 |
2020-07-30 |
Research Institute At Nationwide Children's Hospital |
A novel method for monitoring and treating oral cancer
|
KR20210139237A
(ko)
|
2019-03-14 |
2021-11-22 |
더 리서치 파운데이션 포 더 스테이트 유니버시티 오브 뉴욕 |
변형된 마이크로rna 및 암 치료에 있어서의 이의 용도
|
EP4058152A4
(en)
|
2019-11-14 |
2024-05-08 |
The Board of Regents of the University of Oklahoma |
PROSTATE CANCER TREATMENTS USING OLIGONUCLEOTIDES INTERFERENCE
|
US11965162B2
(en)
|
2020-04-16 |
2024-04-23 |
The Johns Hopkins University |
MicroRNA and inhibitors thereof and methods of treatment
|
WO2021262919A2
(en)
|
2020-06-26 |
2021-12-30 |
The Research Foundation For The State University Of New York |
5-halouracil-modified micrornas and their use in the treatment of cancer
|